Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Security class unavailable · CUSIP: 140755109

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,415,491
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-19-002656
Form type
SC 13G
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub